BioSpace News Archive

The BioAlberta Board of Directors announced today that Mr. Robb Stoddard has been appointed BioAlberta’s new President and CEO.

Marmon Holdings, Inc., a Berkshire Hathaway company, today announced it has acquired a majority interest in the Colson Medical Companies, a global provider of specialty medical devices, from Colson Associates, Inc.

Colorado BioScience Association today unveils a new website and bold brand signaling a commitment to create co-opportunity for life sciences in Colorado

IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the “Company” or “IntelGenx”), a leader in pharmaceutical films, today announced that it will release its third quarter 2019 financial results after market close on November 7, 2019.

A new, four-year collective bargaining agreement between Kaiser Permanente and the Coalition of Kaiser Permanente Unions is in effect through September 30, 2023.

At Solidarity HealthShare, we facilitate our members’ healthcare costs and negotiate transparent, reasonable pricing, on average saving 60%, allowing members to can keep their doctors

PurpleStride Supports the Pancreatic Cancer Action Network’s Urgent Mission to Save Lives and Double Pancreatic Cancer Survival

Titan Medical Inc. is pleased to announce that it has filed and been receipted for a final short form prospectus in connection with the previously announced marketed offering of units of the Company at a price of US $0.45 per Unit for minimum gross proceeds of US $15,000,000 and maximum gross proceeds of US $25,000,000.

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that on October 30, 2019, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 81,000 shares of its common stock to 61 new employees under Xeris’ Inducement Equity Plan.

Americans deserve to have confidence in the quality of drugs the U.S. Food and Drug Administration regulates – from the prescription medicines they take to the over-the-counter (OTC) products they use in their daily lives. Helping assure the quality and safety of these products is one of our greatest responsibilities